Results 51 to 60 of about 24,049 (149)
Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer
, 2022 Ting Xu, Lirong Wu, Saumil Gandhi, Jing Wang, Quyhn-Nhu Nguyen, Aileen B. Chen, Joe Y. Chang, Roza Nurieva, Ajay Sheshadri, Mehmet Altan, Percy P. Lee, Steven H. Lin, Zhongxing Liao +12 moreopenalex +2 more sourcesSupplementary Figure from Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors [PDF]
, 2023 Jonathan W. Goldman, Sarina A. Piha‐Paul, Brendan D. Curti, Katrina S. Pedersen, Todd M. Bauer, Stefanie L. Groenland, Richard D. Carvajal, Vaishali Chhaya, Gray Kirby, Kelly McGlinchey, Scott A. Hammond, Katie Streicher, Danielle M. Townsley, Young Kwang Chae, Jens Voortman, Aurélien Marabelle, John D. Powderly +16 moreopenalex +1 more sourceExtracellular matrix-myCAF signatures correlate with resistance to neoadjuvant aPD-L1 immune checkpoint inhibition with durvalumab + metformin in HPV+ HNSCC [PDF]
Pablo Llerena, Hani Samarah, Kathryn L. Nunes, Zhao Lin, Kelly Bridgham, Sruti Tekumalla, Amiti Jain, Larry A. Harshyne, Sanket Kumar Shukla, Ioannis Vathiotis, Madalina Tuluc, Stacey Gargano, John R. Eisenbrey, Scott W. Keith, David M. Cognetti, Voichita Bar‐Ad, Adam Luginbuhl, Rita Axelrod, Rajanikanth Vadigepalli, Hushan Yang, Diana Whitaker‐Menezes, Megan Roche, Mỹ G. Mahoney, Athanassios Argiris, Charalambos Solomides, Jennifer M. Johnson, Mouadh Barbirou, Amanda Miller, Andrew P. South, Ramkrishna Mitra, Alban J. Linnenbach, Ubaldo Martinez‐Outschoorn, Joseph Curry +32 moreopenalex +1 more sourceSupplementary Table from A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma
, 2023 Martin H. Voss, Arun Azad, Aaron R. Hansen, Jhanelle E. Gray, Sarah J. Welsh, Xuyang Song, Michael Kuziora, Lina Meinecke, Jorge Blando, Ikbel Achour, Yi Wang, Farzana L. Walcott, Sjoukje F. Oosting +12 moreopenalex +1 more sourcePredictive factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer [PDF]
, 2021 Hiroshi Mayahara, Kazuyuki Uehara, Aya Harada, Keiji Kitatani, Tomonori Yabuuchi, Shuichirou Miyazaki, Takeaki Ishihara, Hiroki Kawaguchi, Hikaru Kubota, Hideaki Okada, Taira Ninomaru, Chihiro Shindo, Akito Hata +12 moreopenalex +1 more sourceSupplementary Figure from Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
, 2023 Kim Blenman, Michał Marczyk, Thomas Karn, Qing Tao, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Ibrahim, Tristen Park, Andrea Silber, Denise M. Wolf, Emily Reisenbichler, Carsten Denkert, Bruno V. Sinn, Mariya Rozenblit, Julia Foldi, David L. Rimm, Sibylle Loibl, Lajos Pusztai +19 moreopenalex +1 more source